Document 0168
 DOCN  M9650168
 TI    [Therapy and prevention of pneumocystis carinii pneumonia]
 DT    9605
 AU    Goebel FD; Bogner JR; Medizinische Poliklinik, Klinikum Innenstadt,;
       Ludwig-Maximilians-Universitat, Munchen.
 SO    Internist (Berl). 1995 Dec;36(12):1150-5. Unique Identifier : AIDSLINE
       MED/96137007
 DE    Animal  Antifungal Agents/ADVERSE EFFECTS/*THERAPEUTIC USE  AIDS-Related
       Opportunistic Infections/DIAGNOSIS/*DRUG THERAPY/  PREVENTION & CONTROL
       Clindamycin/ADVERSE EFFECTS/THERAPEUTIC USE  Clinical Trials
       Dapsone/ADVERSE EFFECTS/THERAPEUTIC USE  Human  Naphthoquinones/ADVERSE
       EFFECTS/THERAPEUTIC USE  Pentamidine/ADVERSE EFFECTS/THERAPEUTIC USE
       Pneumonia, Pneumocystis carinii/DIAGNOSIS/*DRUG THERAPY/  PREVENTION &
       CONTROL  Primaquine/ADVERSE EFFECTS/THERAPEUTIC USE
       Trimethoprim-Sulfamethoxazole Combination/ADVERSE EFFECTS/  THERAPEUTIC
       USE  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).